Impact of lung cancer screening results on smoking cessation
- PMID: 24872540
- PMCID: PMC4081623
- DOI: 10.1093/jnci/dju084
Impact of lung cancer screening results on smoking cessation
Abstract
Background: Lung cancer screening programs may provide opportunities to reduce smoking rates among participants. This study evaluates the impact of lung cancer screening results on smoking cessation.
Methods: Data from Lung Screening Study participants in the National Lung Screening Trial (NLST; 2002-2009) were used to prepare multivariable longitudinal regression models predicting annual smoking cessation in those who were current smokers at study entry (n = 15489, excluding those developing lung cancer in follow-up). The associations of lung cancer screening results on smoking cessation over the trial period were analyzed. All hypothesis testing used two sided P values.
Results: In adjusted analyses, smoking cessation was strongly associated with the amount of abnormality observed in the previous year's screening (P < .0001). Compared with those with a normal screen, individuals were less likely to be smokers if their previous year's screen had a major abnormality that was not suspicious for lung cancer (odds ratio [OR] = 0.811; 95% confidence interval [CI] = 0.722 to 0.912; P < .001), was suspicious for lung cancer but stable from previous screens (OR = 0.785; 95% CI = 0.706 to 0.872; P < .001), or was suspicious for lung cancer and was new or changed from the previous screen (OR = 0.663; 95% CI = 0.607 to 0.724; P < .001). Differences in smoking prevalence were present up to 5 years after the last screen.
Conclusions: Smoking cessation is statistically significantly associated with screen-detected abnormality. Integration of effective smoking cessation programs within screening programs should lead to further reduction in smoking-related morbidity and mortality.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Lung cancer screening and smoking cessation: a teachable moment?J Natl Cancer Inst. 2014 May 28;106(6):dju122. doi: 10.1093/jnci/dju122. Print 2014 Jun. J Natl Cancer Inst. 2014. PMID: 24872542 Free PMC article. No abstract available.
Similar articles
-
Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.J Natl Cancer Inst. 2012 Nov 7;104(21):1647-59. doi: 10.1093/jnci/djs398. Epub 2012 Oct 26. J Natl Cancer Inst. 2012. PMID: 23104210 Free PMC article. Clinical Trial.
-
Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial.JAMA Intern Med. 2015 Sep;175(9):1509-16. doi: 10.1001/jamainternmed.2015.2391. JAMA Intern Med. 2015. PMID: 26076313 Free PMC article. Clinical Trial.
-
The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.Am J Respir Crit Care Med. 2016 Mar 1;193(5):534-41. doi: 10.1164/rccm.201507-1420OC. Am J Respir Crit Care Med. 2016. PMID: 26502000 Clinical Trial.
-
Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration.Am J Respir Crit Care Med. 2018 Jan 15;197(2):172-182. doi: 10.1164/rccm.201705-0909CI. Am J Respir Crit Care Med. 2018. PMID: 28977754 Free PMC article. Review.
-
The impact of computed tomography screening for lung cancer on smoking behaviors: a teachable moment?Cancer Nurs. 2012 Nov-Dec;35(6):446-75. doi: 10.1097/NCC.0b013e3182406297. Cancer Nurs. 2012. PMID: 22209869 Review.
Cited by
-
O-GlcNAcylation of hexokinase 2 modulates mitochondrial dynamics and enhances the progression of lung cancer.Mol Cell Biochem. 2024 Nov 4. doi: 10.1007/s11010-024-05146-2. Online ahead of print. Mol Cell Biochem. 2024. PMID: 39496915
-
Beyond lung cancer screening, an opportunity for early detection of chronic obstructive pulmonary disease and cardiovascular diseases.JNCI Cancer Spectr. 2024 Sep 2;8(5):pkae082. doi: 10.1093/jncics/pkae082. JNCI Cancer Spectr. 2024. PMID: 39270051 Free PMC article.
-
Prevalence and management of pulmonary nodules: a systematic review and meta-analysis.J Thorac Dis. 2024 Jul 30;16(7):4619-4632. doi: 10.21037/jtd-24-874. Epub 2024 Jul 24. J Thorac Dis. 2024. PMID: 39144359 Free PMC article.
-
Smartphone application versus written material for smoking reduction and cessation in individuals undergoing low-dose computed tomography (LDCT) screening for lung cancer: a phase II open-label randomised controlled trial.Lancet Reg Health Eur. 2024 May 25;42:100946. doi: 10.1016/j.lanepe.2024.100946. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 39070744 Free PMC article.
-
Cigarette smoke promotes IL-6-dependent lung cancer migration and osteolytic bone metastasis.Int J Biol Sci. 2024 Jun 3;20(9):3257-3268. doi: 10.7150/ijbs.94339. eCollection 2024. Int J Biol Sci. 2024. PMID: 38993553 Free PMC article.
References
-
- Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013. [published ahead of print December 31, 2013]. - PubMed
-
- Jacobson FL, Austin JH, Field JK, et al. Development of the American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of the American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg. 2012;144(1):25–32 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
